BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23519732)

  • 1. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
    Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
    Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
    Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
    Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
    Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
    Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the DYSF mutational spectrum in a large cohort of patients.
    Krahn M; Béroud C; Labelle V; Nguyen K; Bernard R; Bassez G; Figarella-Branger D; Fernandez C; Bouvenot J; Richard I; Ollagnon-Roman E; Bevilacqua JA; Salvo E; Attarian S; Chapon F; Pellissier JF; Pouget J; Hammouda el H; Laforêt P; Urtizberea JA; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2009 Feb; 30(2):E345-75. PubMed ID: 18853459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.
    Vilchez JJ; Gallano P; Gallardo E; Lasa A; Rojas-García R; Freixas A; De Luna N; Calafell F; Sevilla T; Mayordomo F; Baiget M; Illa I
    Arch Neurol; 2005 Aug; 62(8):1256-9. PubMed ID: 16087766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
    Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
    Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
    Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
    Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges for the genetic screening in dysferlin deficiency--report of an instructive case and review of the literature.
    Gal A; Siska E; Nagy Z; Karpati G; Molnar MJ
    Clin Neuropathol; 2008; 27(5):289-94. PubMed ID: 18808059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysferlin homozygous mutation G1418D causes limb-girdle type 2B in a Mexican family.
    Rosas-Vargas H; Gómez-Díaz B; Ruano-Calderón L; Fernández-Valverde F; Roque-Ramírez B; Portillo-Bobadilla T; Ordoñez-Razo RM; Minauro-Sanmiguel F; Coral-Vázquez R
    Genet Test; 2007; 11(4):391-6. PubMed ID: 18294055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of dysferlinopathy presenting choreic movements.
    Takahashi T; Aoki M; Imai T; Yoshioka M; Konno H; Higano S; Onodera Y; Saito H; Kimura I; Itoyama Y
    Mov Disord; 2006 Sep; 21(9):1513-5. PubMed ID: 16817213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
    Piccolo F; Moore SA; Ford GC; Campbell KP
    Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Private dysferlin exon skipping mutation (c.5492G>A) with a founder effect reveals further alternative splicing involving exons 49-51.
    Santos R; Oliveira J; Vieira E; Coelho T; Carneiro AL; Evangelista T; Dias C; Fortuna A; Geraldo A; Negrão L; Guimarães A; Bronze-da-Rocha E
    J Hum Genet; 2010 Aug; 55(8):546-9. PubMed ID: 20535123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation impact on dysferlin inferred from database analysis and computer-based structural predictions.
    Therrien C; Dodig D; Karpati G; Sinnreich M
    J Neurol Sci; 2006 Dec; 250(1-2):71-8. PubMed ID: 16996541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
    Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP
    Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic overview of blood-based dysferlin protein assay for dysferlinopathies.
    Ankala A; Nallamilli BR; Rufibach LE; Hwang E; Hegde MR
    Muscle Nerve; 2014 Sep; 50(3):333-9. PubMed ID: 24488599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects on patients affected by dysferlin deficient muscular dystrophy.
    Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.